Related Experiment Video
Updated: Aug 10, 2025
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.3K
Giant cell arteritis: reviewing the advancing diagnostics and management
Edward J Bilton1,2, Susan P Mollan3,4,5
1Ophthalmology Department, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Eye (London, England)
|February 14, 2023
Summary
Giant Cell Arteritis (GCA) is a serious condition often causing vision loss. Recent advances in diagnosis and treatment, including cranial ultrasound and new therapies, aim to improve outcomes for patients.
Area of Science:
- Rheumatology
- Ophthalmology
- Immunology
Background:
- Giant Cell Arteritis (GCA) is a critical ischemic disease requiring prompt medical attention.
- Despite treatment, visual loss affects a significant proportion of patients.
- Understanding the immunopathophysiology and the role of aging in GCA is evolving.
Purpose of the Study:
- To review the latest advancements in Giant Cell Arteritis (GCA).
- To highlight potential influences on routine clinical practice for GCA management.
Main Methods:
- Review of recent national and international guidelines.
- Analysis of clinical trial data for targeted therapies.
- Discussion of diagnostic tools like cranial ultrasound.
Main Results:
- Cranial ultrasound is recommended to reduce diagnostic delays and improve outcomes.
- Targeted agents demonstrate superior efficacy and steroid-sparing effects compared to standard treatment.
- New insights into the role of aging in GCA development are emerging.
Conclusions:
- Recent advances in GCA diagnosis and treatment offer improved clinical outcomes.
- New therapeutic strategies show promise for better efficacy and reduced steroid dependence.
- Continued research into GCA pathogenesis, including aging, is crucial for further advancements.
More Related Videos
Related Concept Videos
01:26Aneurysm III: Interprofessional Care
16
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
16
01:26Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
01:21Rheumatic Heart Disease III: Medical Management
24
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
24
01:27Peripheral Artery Disease III: Interprofessional Care
17
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
17
01:25Aortic Regurgitation III: Medical Management
32
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
01:14Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13